SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: Doug R who wrote (40227)12/3/2001 1:20:49 PM
From: Sergio H  Read Replies (1) | Respond to of 79273
 
Doug, CLGY is "In Play"

From briefing.com:

<Cellegy Pharma (CLGY) 7.50: Submits a supplement to its NDA, one month ahead of schedule, for Anogesic to include data from a recently completed confirmatory Phase III clinical study using Anogesic to treat pain associated with chronic anal fissures. The Anogesic NDA was originally filed in June 2001.>

I think there's going to be lots of news from this stock over the next year.

Sergio



To: Doug R who wrote (40227)12/30/2001 1:08:00 PM
From: Sergio H  Respond to of 79273
 
Hi Doug.

An update on a couple of the stocks we were discussing;

CLGY hit a new high in short term and is getting ready for another run.

EXAC hit it's first target. There was positive news after the bell on Friday and should approach filling the overhead gap and shortly move towards the second target price.

Happy New Year to all of the 56ers.

Sergio


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News